pancreatic cancerSubscribe to pancreatic cancer

A diagnosis of pancreatic cancer is often a death sentence because current chemotherapies have little impact on the disease. 

An Australian-led international research effort has revealed that genetic changes normally linked to breast, colon and ovarian cancers could also drive a rare form of pancreatic cancer.

A bid to improve near-zero survival rates for pancreatic cancer will receive a boost with the creation of Australia’s first pancreatic cancer ‘organoids bank’, enabling researchers to bring down the time it takes to find individualised chemotherapy treatment within weeks rather than months.

An international team led by Australian researchers has studied the genetics of pancreatic cancer, revealing it is actually four separate diseases, with different genetic triggers and survival rates, paving the way for more accurate diagnoses and treatments.